Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-18

Clinical Trial Update: A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin

View source ↗

Summary

Post-marketing surveillance study evaluating efficacy, safety, and tolerability of pregabalin (Lyrica) in neuropathic pain; completed with results posted in 200…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuropathic Pain | Status: COMPLETED | Results posted: 2009-11-18